Net Cash Provided by (Used in) Operating Activities of Alzamend Neuro, Inc. from 30 Apr 2020 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Alzamend Neuro, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Apr 2020 to 31 Jul 2025.
  • Alzamend Neuro, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Jul 2025 was $2,362,786, a 124% decline year-over-year.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $6,568,186, a 21% increase from 2023.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $8,269,993, a 7.3% increase from 2022.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $8,923,152, a 35% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Alzamend Neuro, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,362,786 -$1,307,044 -124% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025 2026 Q1
Q2 2024 $1,055,742 +$2,242,458 +68% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025 2026 Q1
Q2 2023 $3,298,200 -$761,510 -30% 01 May 2023 31 Jul 2023 10-Q 11 Sep 2024 2024 Q1
Q2 2022 $2,536,690 -$1,314,026 -107% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1
Q2 2021 $1,222,664 -$1,017,568 -496% 01 May 2021 31 Jul 2021 10-Q 13 Sep 2022 2022 Q1
Q2 2020 $205,096 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1

Alzamend Neuro, Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,568,186 +$1,701,807 +21% 01 May 2024 30 Apr 2025 10-K 22 Jul 2025 2025 FY
2023 $8,269,993 +$653,159 +7.3% 01 May 2023 30 Apr 2024 10-K 22 Jul 2025 2025 FY
2022 $8,923,152 -$2,309,162 -35% 01 May 2022 30 Apr 2023 10-K 30 Jul 2024 2024 FY
2021 $6,613,990 -$3,901,963 -144% 01 May 2021 30 Apr 2022 10-K 27 Jul 2023 2023 FY
2020 $2,712,027 -$366,237 -16% 01 May 2020 30 Apr 2021 10-K 19 Jul 2022 2022 FY
2019 $2,345,790 01 May 2019 30 Apr 2020 10-K 29 Jul 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.